TH177311B - Protein fusion - Google Patents

Protein fusion

Info

Publication number
TH177311B
TH177311B TH1701006531A TH1701006531A TH177311B TH 177311 B TH177311 B TH 177311B TH 1701006531 A TH1701006531 A TH 1701006531A TH 1701006531 A TH1701006531 A TH 1701006531A TH 177311 B TH177311 B TH 177311B
Authority
TH
Thailand
Prior art keywords
protein fusion
insulin
ocr
clause
agonist
Prior art date
Application number
TH1701006531A
Other languages
Thai (th)
Other versions
TH177311A (en
Original Assignee
อีไล ลิลลี่ แอนด์ คัมปะนี
Filing date
Publication date
Application filed by อีไล ลิลลี่ แอนด์ คัมปะนี filed Critical อีไล ลิลลี่ แอนด์ คัมปะนี
Publication of TH177311B publication Critical patent/TH177311B/en
Publication of TH177311A publication Critical patent/TH177311A/en

Links

Claims (1)

------09/11/2560------(OCR) หน้า 1 ของจำนวน 4 หน้า ข้อถือสิทธิ 1. ฟิวชันโปรตีนที่ประกอบรวมด้วย (a) อะโกนิสท์ของหน่วยรับอินซูลินที่มีสูตรสามัญ Z1-Z2-Z3, โดยที่: i) Z1 คืออะนาล็อกสาย B ของอินซูลินที่ประกอบรวมด้วยลำดับกรดอะมิโน: X1X2X3QHLCGSHLVEALX4LVCGERGFX5YXGX7X8X9 โดยที่ X1 คือ F, Q หรือ A; X2 คือ V หรือ G; X3 คือ N, K, D, G, Q, A หรือ E; X4 คือ E, Y, Q, หรือ H; X5 คือ H หรือ F; X6 คือ G, T, S, H, V หรือไม่มีอ:------ 09/11/2017 ------ (OCR) page 1 of 4 pages. Clause 1. Protein fusion consisting of (a) agonist of receptor Insulin with the generic formula Z1-Z2-Z3, where: i) Z1 is an B-line analog of insulin that is composed of an amino acid sequence: X1X2X3QHLCGSHLVEALX4LVCGERGFX5YXGX7X8X9 where X1 is F, Q, or A; X2 is V, or G; X3 is N, K, D, G, Q, A, or E; X4 is E, Y, Q, or H; X5 is H or F; X6 is G, T, S, H, V, or without:
TH1701006531A 2016-04-28 Protein fusion TH177311A (en)

Publications (2)

Publication Number Publication Date
TH177311B true TH177311B (en) 2018-06-28
TH177311A TH177311A (en) 2018-06-28

Family

ID=

Similar Documents

Publication Publication Date Title
EA201792651A1 (en) Adenoviral polynucleotides and polypeptides
BR112017007816A2 (en) pharmaceutical compositions comprising peptide variants and methods of using them
WO2016071376A3 (en) Fc-region variants with modified fcrn-binding and methods of use
DK3707261T3 (en) Fusion proteins based on human ferritin and protease-cleavable peptides and their use as chemotherapy carriers
BR112018013246A2 (en) peptide label and labeled protein including the same
EA201591609A1 (en) ALPHA-AMILASE OPTIONS
TH177311B (en) Protein fusion
TH177311A (en) Protein fusion
EA202090143A1 (en) PHARMACEUTALLY ACCEPTABLE SALTS OF POLYPEPTIDES AND THEIR APPLICATION
TH176997A (en) CD44v6-derived cyclic peptide for the treatment of cancer and related diseases. With the creation of new blood vessels
TH175588A (en) KZ144 modified endolysin sequence
TH178974A (en) Fusion protein
Napetvaridze The use of history in the process of political science teaching
TH182858A (en) A new protein specific to poverodine and piokily.
HD SUPER-EGO
TH179215A (en) Protein variants of the amino acid sequence Cry1Da1 that are active against Lepidopteran.
TH181595A (en) "TATk-CDKL5 aggregate protein, composition, formulation and application Such things "
TH1501004062A (en) Antifungal polypeptides that cause disease in plants
Aliev THE BOOK OF BURKUN-DARGO. Review on the book by Kurbanov M.-ZY «Burkun-Dargo. History, culture and way of life: the past and the present».-Makhachkala: Nauka-Dagestan, 2015
RU2017122766A (en) STRAIN E.coli JM109 / pQE80-HSP70-RecEp2 - PRODUCER OF FUSION PROTEIN CONSISTING OF HSPA1B AND HLA-A2 HUMAN RECOVER EPITOPE
EA202092327A1 (en) LFA3 OPTIONS AND THEIR COMPOSITIONS AND APPLICATIONS
TH1701005732A (en) New and holistic peptide and skeletal peptides for use in immunotherapy, anti-cancer of the kidney tissue (RCC) and other cancers.
TH174243A (en) Xylose-containing proteins Isomeres and the use of the same
TH1901003157A (en) trehalose phosphorylase
TH180797A (en) Modified colostrum protein and its use